Dogwood Therapeutics (DWTX) Intangibles (2024 - 2026)

Dogwood Therapeutics has reported Intangibles for 3 years, with the latest figure at $57.3 million in Q2 2026.

• On a quarterly basis, Intangibles fell 17.25% year-over-year to $57.3 million in Q2 2026; TTM through Jun 2026 was $57.3 million, a 17.25% decrease from a year earlier, with the FY2025 full-year figure at $69.0 million, up 4.98% from the prior year.
• Intangibles was $57.3 million for Q2 2026 at Dogwood Therapeutics, down from $67.8 million in the prior quarter.
• The five-year high for Intangibles was $69.3 million in Q2 2025, with the low at $57.3 million in Q2 2026.
• Average Intangibles over 3 years is $66.1 million, with a median of $67.8 million recorded in 2026.
• The sharpest annual moves came in 2025 and 2026: Intangibles climbed 4.98% in 2025, then dropped 17.25% in 2026.
• Over 3 years, Intangibles stood at $65.7 million in 2024, then gained by 4.98% to $69.0 million in 2025, then decreased by 16.87% to $57.3 million in 2026.
• The last three Intangibles figures came in at $57.3 million (Q2 2026), $67.8 million (Q1 2026), and $69.0 million (Q4 2025), per Business Quant data.